机译:儿心房颤动患者籼稻的人口药代动力学和药物转基因组
Laboratory of Clinical Pharmaceutics and Therapeutics College of Pharmaceutical;
Department of PharmacyShiga University of Medical Science HospitalSeta Tsukinowa‐Cho Otsu Shiga 520;
Laboratory of Clinical Pharmaceutics and Therapeutics College of Pharmaceutical;
Laboratory of Clinical Pharmaceutics and Therapeutics College of Pharmaceutical;
Laboratory of Clinical Pharmaceutics and Therapeutics College of Pharmaceutical;
Laboratory of Clinical Pharmaceutics and Therapeutics College of Pharmaceutical;
Department of PharmacyShiga University of Medical Science HospitalSeta Tsukinowa‐Cho Otsu Shiga 520;
Department of Cardiovascular and Respiratory MedicineShiga University of Medical ScienceSeta;
Department of Cardiovascular and Respiratory MedicineShiga University of Medical ScienceSeta;
Department of Cardiovascular and Respiratory MedicineShiga University of Medical ScienceSeta;
Department of Cardiovascular and Respiratory MedicineShiga University of Medical ScienceSeta;
Department of PharmacyShiga University of Medical Science HospitalSeta Tsukinowa‐Cho Otsu Shiga 520;
Laboratory of Clinical Pharmaceutics and Therapeutics College of Pharmaceutical;
cytochrome P450; drug transporters; genetic polymorphism; pharmacogenomics; population analysis;
机译:儿心房颤动患者籼稻的人口药代动力学和药物转基因组
机译:抗凝血剂Apixaban,Dabigatran,Edoxaban和Rivaroxaban在一所综合医院治疗的老年人患者的老年日本人患者
机译:在德国未选择患者的非瓣膜心房颤动患者中使用,持续,疗效和安全性。心房颤动前瞻性Apixaban的结果(APAF)登记处
机译:心房颤动患者的房间隔和阑尾口:一项人口研究
机译:阿哌沙班,达比加群,利伐沙班和华法林预防房颤预防中风的成本效益。
机译:日本成人房颤患者阿哌沙班的群体药代动力学和药物基因组学
机译:日本心房颤动患者中紫杉醇的人口药代动力学和药效学